Toronto, Ontario — North American collision repair provider CARSTAR is celebrating a milestone after raising more than $4 million for cystic fibrosis research, care and advocacy.
“Our franchise family works tremendously hard to host events that raise valuable funds and awareness in their respective communities for cystic fibrosis,” says Dean Fisher, president of CARSTAR. “It is directly because of them and the additional support of our vendor, insurance and corporate partners that we are able to enjoy this milestone moment together.”
“CARSTAR and its partners are a great example of the impact that can be made through corporate philanthropy,” said Kelly Grover, president and CEO, Cystic Fibrosis Canada. “The funds raised by CARSTAR will help people living with cystic fibrosis live longer, healthier lives. Thank you for your generosity.”
Cystic fibrosis is a fatal genetic disease with no cure. The disease causes various effects on the body, but mainly affects the digestive system and lungs. A defective gene causes a thick, buildup of mucus in the lungs, pancreas, and other organs leading to infections, extensive lung damage, and eventually, respiratory failure.
CARSTAR began fundraising for cystic fibrosis in Canada more than 20 years ago when a franchise partner’s granddaughter received a cystic fibrosis diagnosis. Since then, the CARSTAR commitment to its charity of choice has only accelerated. Whether it is hosting a car wash, golf tournament, participating in a charity walk, holding a garage sale or providing a simple donation—every initiative large and small has helped the company raise $4 million for its cystic fibrosis partners.
To donate to Cystic Fibrosis Canada, click here.
For more information on CARSTAR, visit CARSTAR.ca.
